NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00296322,Trial of Adjuvant Chemotherapy for Gastric Cancer,https://clinicaltrials.gov/study/NCT00296322,,COMPLETED,This study is designed to evaluate the efficacy of the intraperitoneal chemotherapy with early mitomycin administration and adding cisplatin to prolonged treatment with doxifluridine compared to mitomycin plus doxifluridine in resected advanced gastric cancer.,YES,Stomach Cancer,"DRUG: cisplatin, mitomycin-C, doxifluridine","Relapse-free Survival, 3 years","Toxicity Profile (According to NCI CTC Version 2.0), Because safety profile in oncology study is evaluated for each toxicity, it is impossible to present the overall patient number. Instead, we presented the number of patients who declined study therapy due to adverse events or patient will., up to 1 year|Overall Survival, 3 years",,Asan Medical Center,Ulsan University Hospital|Hallym University Medical Center,ALL,"ADULT, OLDER_ADULT",PHASE3,528,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,AMC0102,2001-10,2007-12,2010-03,2006-02-27,2012-09-06,2020-01-18,"Asan Medical Center, Seoul, 138-736, Korea, Republic of",
